The IACG on AMR released the draft recommendations for public discussion from 29 January to 19 February. This marks the final round of stakeholder input collection before the recommendations are finalized for submission to the UN Secretary General by April 2019. The process towards the UN General Assembly will greatly determine the strategic directions of global response to antimicrobial resistance.
ReAct has developed our main opinions on the draft recommendations and also joined the Antibiotic Resistance Coalition (ARC) discussions for collective civil society response.
The The Ad hoc Inter-Agency Coordination Group on Antimicrobial Resistance (IACG) draft recommendations fall within five broad areas:
- Accelerate progress in countries.
- Innovate to secure the future.
- Collaborate for more effective action.
- Invest for a sustainable response.
- Strengthen global accountability and governance.
Country engagement and ownership are critical to lead the way towards a lasting global response for managing antimicrobial resistance. ReAct urges countries to actively engage in and follow up the IACG process, come together to act decisively and voice views from low- and middle-income countries.
Seven high-level standpoints from ReAct corresponding to the IACG draft recommendations:
1. We commend IACG on the strong emphasis on affordable and equitable access throughout the recommendations, and the link with the principles from the Political Declaration. There are strong reasons to reiterate the importance that present and future initiatives should follow all the principles already agreed on by the Member States.
2. There is a lack of reflection on the process and the ways forward on how to implement the recommendations. We wish to see a more clear suggestion on who should be responsible to carry forward the recommendations, and more closely link them with global and national mandates and mechanisms for accountability.
3. The relevance and importance of the individual recommendations would benefit from being framed within a larger systems perspective. All recommendations are connected and important for taking action. For example the role of civil society and how important their contribution to accelerate implementation of National Action Plans.
4. Make the urgency of reacting to the challenge of antimicrobial resistance more prominent in the recommendations. The imminent and already present threat posed by antimicrobial resistance must come across more strongly and that policy makers must urgently act and make it in connection with a pay now or pay much more later argument.
5. Target-setting must be emphasized much more prominently throughout the recommendations. Targets must be set both at the country level and globally. Measurable and achievable milestones will serve as a crucial accountability mechanism.
6. Conflicts of interest must be addressed at all levels of the recommendations, particularly where industry is suggested to play a role or contribute in global governance, financing, and implementing interventions on stewardship or access.
7. The recommendations should more strongly emphasize the need to mainstream AMR into broader agendas on universal health coverage, sustainable development, water and sanitation, infection prevention and control, food production and sustainable environment.
Reflections from ReAct for more thorough consideration – this under specific areas in the recommendations
Country action is key for success. Practical and feasible actions to implement at country level are worth lifting up in the main recommendations, including target setting, addressing shortages, surveillance, as well as capacity building and supporting national champions.
We support the IACG that funding must be mobilized for innovation and call for the lifting of the need for investments and innovation across different areas of research and development, including a broader research agenda.
We commend that IACG lifts the important role of civil society organizations (CSOs) in accountability, advocacy, monitoring progress and ensuring prudent use of antimicrobials.
Conflict of interest and due diligence regarding private sector engagement must be addressed. It is of particular concern that the recommendations promote the engagement of the private sector in ensuring access, equity, prudent use and stewardship. The public sector must be in charge of securing access and equity, so it would be important that this role of the public sector is much more prominent in the recommendations.
We call for a stronger emphasis on the urgency of resource mobilization and more concrete proposals on financial solutions at both global and country levels for the near future and longer term.
We commend that concrete proposals for global governance are suggested and would like to see greater clarity when describing the different levels of governance mechanism and who is accountable to drive the processes to create these new entities.
More news and opinion from 2019
- ReAct’s 2019 wrap up and 2020 expectations
- Blog post by UNDP and ReAct: Antimicrobial resistance: An emerging crisis
- Water, sanitation and hygiene services critical to curbing antibiotic quick fix
- Diagnostics: Antibiotic susceptibility
- ReAct highlights during World Antibiotic Awareness week 2019
- 2019 AMR photo competition prizes announced
- Launch of UNICEF’s institutional guidance on antimicrobial resistance
- Proposed ban on colistin for animal use announced in Indonesia
- School children led celebration of World Toilet Day and World Antibiotic Awareness Week
- 10 Innovate4AMR-winning teams enjoyed 3-day workshop in Geneva
- After 4 collaborative meeting days: Actions for the future in Latin America
- Four key points from joint comments to One Health Global Leaders Group on AMR
- Why are children more vulnerable to AMR?
- Dr Yoel Lubell, Health Economist, on Thailand, AMR, UCH and cultural factors driving AMR
- UHC and AMR: The Thai Experience
- Why do effective antibiotics matter for quality of care and patient safety?
- New ReAct policy brief: Antimicrobial resistance and universal health coverage – What’s the deal?
- Three key takeaways from the ReAct Africa conference
- Diagnostics: Species identification
- AMR-specific indicator proposed for monitoring Sustainable Development Goals
- Five focus areas at the 2nd Ministerial Conference on AMR hosted by the Netherlands
- Safety concerns of fecal microbiota transplants
- Upcoming ReAct Africa Conference: universal health coverage and antimicrobial resistance in focus
- Mother Earth conference in Argentina – the environment in focus
- Diagnostics: What are we talking about?
- Connecting global to local civil-society-agenda on AMR at CSO convening in Geneva
- ReAct colleagues featured in WHO Bulletin as leading profiles in the work on reacting to antibiotic resistance
- RAN stakeholder at WHO IPC consultation – for standards and guidelines in African Union member states
- WHA conversation on Antibiotic Resistance as a Global Development Problem co-organized by ReAct
- Insights from ReAct Asia Pacific project on antibiotic stewardship in secondary level hospitals in India
- Open letter to UN Member States from former IACG members Anthony So and Otto Cars
- ReAct UHC Intervention at UNGA Multi-stakeholder Hearing for High-level Meeting on UHC
- ReAct Latin America honors Earth Day
- Medicines Patent Pool’s view on the role of licenses for antibiotics – World Intellectual Property Day
- Second time for Innovate4AMR competition!
- World Health Day 2019: Universal Health Coverage
- Diagnostics: Constraints for successful implementation
- Antibiotic Shortages: magnitude, causes and possible solutions: A new WHO meeting report
- Erry Setyawan, FAO, on Indonesian NAP: We need to work together to make it possible to manage AMR
- ReAct’s new 5-year strategic plan receives funding from Sida
- How infections spread and how to stop them
- Generating data for policy and practice